Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Unexpected guests in the tumor microenvironment: microbiome in cancer

Protein & Cell(2020)10.1007/s13238-020-00813-8Source: DataRank Database

Unexpected guests in the tumor microenvironment: microbiome in cancer is a research paper published in Protein & Cell (2020). On theSindex it has a DataRank of 0.858. It has been cited 304 times.

N/A

0.858DataRank · unranked

Scored on demand from live citation data

Open Access304 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 7.90)OA: goldTopics (32)Linked Datasets (8)DataCite Reuse (8)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.858

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (4)

Haohan Karen Wei,Chen Zhao ORCID,Chengcheng Jin ORCID,Abigail Wong-Rolle ORCID

Live enrichment

PubMed:33296049 PMC:PMC8106554 OpenAlex:https://openalex.org/W3111470573

NCI NIH HHS

Grant: K99 CA226400

NCI NIH HHS

Grant: R00 CA226400

National Institutes of Health

Grant: 5R00CA226400-04

Investigating immune-microbiota interaction in lung cancer

FWCI

7.90

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://link.springer.com/content/pdf/10.1007/s13238-020-00813-8.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s13238-020-00813-8.pdf

publisherhttps://link.springer.com/article/10.1007/s13238-020-00813-8/fulltext.html

journalhttps://doi.org/10.1007/s13238-020-00813-8

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33296049

Fields of Study

Gut microbiota and healthEpigenetics and DNA MethylationCancer Immunotherapy and Biomarkers0301 basic medicine03 medical and health sciences

MeSH Terms

Gastrointestinal MicrobiomeBacteriaHumansNeoplasmsTumor Microenvironment

Keywords

MicrobiomeTumor microenvironmentCancerBiologyBiomarkerCancer researchMechanism (biology)Tumor initiationImmunologyBioinformaticsCarcinogenesisGeneticsImmune systemTumorLung cancerCancer ImmunotherapyTumor-associated MicrobiotaBacteriaNeoplasmsHumansReviewGastrointestinal Microbiome

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of Location and condition based reconstruction of colon cancer microbiome from human RNA sequencing data

10.6084/m9.figshare.22735449.v1figshare

Additional file 1 of Location and condition based reconstruction of colon cancer microbiome from human RNA sequencing data

10.6084/m9.figshare.22735449figshare

Additional file 2 of The intratumoral microbiota biomarkers for predicting survival and efficacy of immunotherapy in patients with ovarian serous cystadenocarcinoma

10.6084/m9.figshare.26195873.v1figshare

Additional file 1 of The intratumoral microbiota biomarkers for predicting survival and efficacy of immunotherapy in patients with ovarian serous cystadenocarcinoma

10.6084/m9.figshare.26195819.v1figshare

Additional file 3 of The intratumoral microbiota biomarkers for predicting survival and efficacy of immunotherapy in patients with ovarian serous cystadenocarcinoma

10.6084/m9.figshare.26744327.v1figshare

Additional file 2 of The intratumoral microbiota biomarkers for predicting survival and efficacy of immunotherapy in patients with ovarian serous cystadenocarcinoma

10.6084/m9.figshare.26195873figshare

Additional file 3 of The intratumoral microbiota biomarkers for predicting survival and efficacy of immunotherapy in patients with ovarian serous cystadenocarcinoma

10.6084/m9.figshare.26744327figshare

Additional file 1 of The intratumoral microbiota biomarkers for predicting survival and efficacy of immunotherapy in patients with ovarian serous cystadenocarcinoma

10.6084/m9.figshare.26195819figshare